Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Maintenance × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, B-Cell, Marginal Zone 2 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 122 Carboplatin 109 Pemetrexed 90 Cisplatin 64 Paclitaxel 55 Nivolumab 40 durvalumab 38 Specimen Handling 38 osimertinib 37 Magnetic Resonance Spectroscopy 32 Docetaxel 29 Gemcitabine 27 atezolizumab 26 cemiplimab 20 130-nm albumin-bound paclitaxel 20 Radiosurgery 18 Drug Therapy 18 Radiotherapy 17 Cetuximab 16 Bevacizumab 16 amivantamab 15 Ipilimumab 15 tislelizumab 12 Immunoglobulin G 12 Taxes 11 Disulfides 11 lazertinib 10 Platinum Compounds 10 Biopsy 10 adagrasib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06656598 2026-02-11

SPORADIC

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡